This book looks at where stem cell technology is presently and how it is instrumental in advancing the field of disease modeling and cell transplantation. By focusing on major human disorders such as Alzheimer’s disease, cancer, and heart disorders, the book summarizes the major findings in the field of human stem cells and dissect the current limitations on our understanding of stem cells biology. The chapters focus on the genetics, genomics, epigenetics and physiology of stem cells models, together with technological advances on molecular biology such as CRISPR/Cas9 or epigenetic editing, that will be instrumental in the future of human disease modeling and treatment.
In base of the limitations of current disease models and in front of the unmet necessity of finding therapeutical interventions for human disorders, the availability of stem cell technology has opened new doors for several fields. The unlimited self-renewal capacity and more extensive differentiation potential of stem cells offers a theoretically inexhaustible and replenishable source of any cell subtype. Since Professor Shinya Yamanaka described it, 10 years ago in his seminal paper, that somatic cells could be reprogrammed to inducible stem cells (iPSC) just by expressing four transcription factors, the field of has exploded, especially its applications in biomedical research.
"synopsis" may belong to another edition of this title.
Raul Delgado-Morales holds a PhD in Neuroscience. He completed his doctoral studies at the Universitat Autònoma de Barcelona working in the field of epigenetics as it relates to depression. After that he received a Marie Curie Postdoctoral Fellowship, to continue his research as a postdoc at the Max Planck Institute of Psychiatry in Munich. There he focused on Alzheimer’s disease. After four years in Germany, he moved to Bellvitge Biomedical Research Institute (IDIBELL), in Barcelona, to lead research on neuroepigenomics. Currently he is the Scientific Deputy Director of IDIBELL.
This book looks at where stem cell technology is presently and how it is instrumental in advancing the field of disease modeling and cell transplantation. By focusing on major human disorders such as Alzheimer’s disease, cancer, and heart disorders, the book summarizes the major findings in the field of human stem cells and dissect the current limitations on our understanding of stem cells biology. The chapters focus on the genetics, genomics, epigenetics and physiology of stem cells models, together with technological advances on molecular biology such as CRISPR/Cas9 or epigenetic editing, that will be instrumental in the future of human disease modeling and treatment.
In base of the limitations of current disease models and in front of the unmet necessity of finding therapeutical interventions for human disorders, the availability of stem cell technology has opened new doors for several fields. The unlimited self-renewal capacity and more extensive differentiation potential of stem cells offers a theoretically inexhaustible and replenishable source of any cell subtype. Since Professor Shinya Yamanaka described it, 10 years ago in his seminal paper, that somatic cells could be reprogrammed to inducible stem cells (iPSC) just by expressing four transcription factors, the field of has exploded, especially its applications in biomedical research.
"About this title" may belong to another edition of this title.
Seller: Universitätsbuchhandlung Herta Hold GmbH, Berlin, Germany
xi, 426 p. Hardcover. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch. Seller Inventory # 2189MB
Seller: Buchpark, Trebbin, Germany
Condition: Hervorragend. Zustand: Hervorragend | Seiten: 440 | Sprache: Englisch | Produktart: Bücher | This book looks at where stem cell technology is presently and how it is instrumental in advancing the field of disease modeling and cell transplantation. By focusing on major human disorders such as Alzheimer¿s disease, cancer, and heart disorders, the book summarizes the major findings in the field of human stem cells and dissect the current limitations on our understanding of stem cells biology. The chapters focus on the genetics, genomics, epigenetics and physiology of stem cells models, together with technological advances on molecular biology such as CRISPR/Cas9 or epigenetic editing, that will be instrumental in the future of human disease modeling and treatment. In base of the limitations of current disease models and in front of the unmet necessity of finding therapeutical interventions for human disorders, the availability of stem cell technology has opened new doors for several fields. The unlimited self-renewal capacity and more extensive differentiation potential of stem cells offers a theoretically inexhaustible and replenishable source of any cell subtype. Since Professor Shinya Yamanaka described it, 10 years ago in his seminal paper, that somatic cells could be reprogrammed to inducible stem cells (iPSC) just by expressing four transcription factors, the field of has exploded, especially its applications in biomedical research. Seller Inventory # 29608255/1
Seller: Brook Bookstore On Demand, Napoli, NA, Italy
Condition: new. Questo è un articolo print on demand. Seller Inventory # c0e86c81a0a70d0d544c4128bfc9e5b1
Quantity: Over 20 available
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book looks at where stem cell technology is presently and how it is instrumentalin advancing the field of disease modeling and cell transplantation. By focusing onmajor human disorders such as Alzheimer's disease, cancer, and heart disorders, thebook summarizes the major findings in the field of human stem cells and dissectthe current limitations on our understanding of stem cells biology. The chaptersfocus on the genetics, genomics, epigenetics and physiology of stem cells models,together with technological advances on molecular biology such as CRISPR/Cas9 orepigenetic editing, that will be instrumental in the future of human disease modelingand treatment.In base of the limitations of current disease models and in front of the unmet necessityof finding therapeutical interventions for human disorders, the availability of stemcell technology has opened new doors for several fields. The unlimited self-renewalcapacity and more extensive differentiation potential of stem cells offers a theoreticallyinexhaustible and replenishable source of any cell subtype. Since Professor ShinyaYamanaka described it, 10 years ago in his seminal paper, that somatic cells could bereprogrammed to inducible stem cells (iPSC) just by expressing four transcriptionfactors, the field of has exploded, especially its applications in biomedical research. 440 pp. Englisch. Seller Inventory # 9783319906942
Seller: moluna, Greven, Germany
Condition: New. Seller Inventory # 220289584
Quantity: Over 20 available
Seller: preigu, Osnabrück, Germany
Buch. Condition: Neu. Stem Cell Genetics for Biomedical Research | Past, Present, and Future | Raul Delgado-Morales | Buch | xi | Englisch | 2018 | Springer International Publishing | EAN 9783319906942 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. Seller Inventory # 112969524
Seller: Kennys Bookshop and Art Galleries Ltd., Galway, GY, Ireland
Condition: New. Seller Inventory # V9783319906942
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND. Seller Inventory # 18376276941
Seller: buchversandmimpf2000, Emtmannsberg, BAYE, Germany
Buch. Condition: Neu. Neuware -This book looks at where stem cell technology is presently and how it is instrumental in advancing the field of disease modeling and cell transplantation. By focusing on major human disorders such as Alzheimer¿s disease, cancer, and heart disorders, the book summarizes the major findings in the field of human stem cells and dissect the current limitations on our understanding of stem cells biology. The chapters focus on the genetics, genomics, epigenetics and physiology of stem cells models, together with technological advances on molecular biology such as CRISPR/Cas9 or epigenetic editing, that will be instrumental in the future of human disease modeling and treatment.In base of the limitations of current disease models and in front of the unmet necessity of finding therapeutical interventions for human disorders, the availability of stem cell technology has opened new doors for several fields. The unlimited self-renewal capacity and more extensive differentiation potential of stem cells offers a theoretically inexhaustible and replenishable source of any cell subtype. Since Professor Shinya Yamanaka described it, 10 years ago in his seminal paper, that somatic cells could be reprogrammed to inducible stem cells (iPSC) just by expressing four transcription factors, the field of has exploded, especially its applications in biomedical research.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 440 pp. Englisch. Seller Inventory # 9783319906942
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - This book looks at where stem cell technology is presently and how it is instrumentalin advancing the field of disease modeling and cell transplantation. By focusing onmajor human disorders such as Alzheimer's disease, cancer, and heart disorders, thebook summarizes the major findings in the field of human stem cells and dissectthe current limitations on our understanding of stem cells biology. The chaptersfocus on the genetics, genomics, epigenetics and physiology of stem cells models,together with technological advances on molecular biology such as CRISPR/Cas9 orepigenetic editing, that will be instrumental in the future of human disease modelingand treatment.In base of the limitations of current disease models and in front of the unmet necessityof finding therapeutical interventions for human disorders, the availability of stemcell technology has opened new doors for several fields. The unlimited self-renewalcapacity and more extensive differentiation potential of stem cells offers a theoreticallyinexhaustible and replenishable source of any cell subtype. Since Professor ShinyaYamanaka described it, 10 years ago in his seminal paper, that somatic cells could bereprogrammed to inducible stem cells (iPSC) just by expressing four transcriptionfactors, the field of has exploded, especially its applications in biomedical research. Seller Inventory # 9783319906942